Serum Heart Type Fatty Acid Binding Protein Levels in Primary Hyperparathyroidism

Creative Commons License

Ucan B., ŞAHİN M., Ozbek M., Caliskan M., Kizilgul M., Ozturk G., ...Daha Fazla

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, cilt.22, sa.1, ss.1-6, 2018 (ESCI, Scopus, TRDizin) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.25179/tjem.2017-57329
  • Dergi Adı: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1-6
  • Anahtar Kelimeler: Hyperparathyroidism, H-FABP, cardiovascular risk, HEALTH-CARE PROFESSIONALS, PARATHYROID-HORMONE, BLOOD-PRESSURE, PULMONARY-EMBOLISM, RISK-FACTORS, FOLLOW-UP, DISEASE, ASSOCIATION, POPULATION, ABNORMALITIES
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Purpose: Recent studies indicate that plasma heart-type fatty acid binding-protein (H-FABP) concentration can be used as an early biochemical marker for macrovascular diseases. Patients with primary hyperparathyroidism (PHT) reportedly display an increase in cardiovascular (CV) risk factors. Our aim was to evaluate plasma H-FABP concentration in these subjects with primary hyperparathyroidism, by comparing them with healthy controls.